CORDIS · 322693 · FP7
STADVINN Strengthening adaptive immunity via innate immunity: enhancing the CD8 T cell response by using the NKG2D ligand expressed in a herpesvirus vector
Coordinator: SVEUCILISTE U RIJECI, MEDICINSKI FAKULTET (HR)
CD8+ T cells play a key role in the control of infections by intracellular pathogens. Recently, several top-notch studies provided ample evidence that NK cells are important in the regulation of CD8+ T cell response. NKG2D is an activating NK cell receptor which plays a role in the adaptive immune response by co-stimulating CD8+ T cells. Due to unique pattern of immune response, live attenuated CMVs are attractive candidates as vaccine vectors for a number of clinically relevant infections. The main idea behind this project stems from our preliminary data which suggest that a recombinant CMV …
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €1.8M awarded to the consortium. The project runs over approximately 5 years from 2013-05-01 to 2018-04-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from HR
see all →- MARBLE — Centre of Excellence in Maritime Robotics and Technologies for Sustainable Blue Economy101136349 · HORIZON · €15.0M
- ANEUPLOIDY — Molecular origins of aneuploidies in healthy and diseased human tissues855158 · H2020 · €10.0M
- InnoThyroGen — Innovating Thyroid Health with Genomics and Predictive Algorithms through Collaborative Excellence101187880 · HORIZON · €4.9M
- INNOMOL — Enhancement of the Innovation Potential in SEE through new Molecular Solutions in Research and Development316289 · FP7 · €4.7M
- GLOWBRAIN — Combining Stem Cells and Biomaterials for Brain Repair - Unlocking the Potential of the Existing Brain Research through Innovative In Vivo Molecular Imaging316120 · FP7 · €3.8M
- ACROSS — Centre of Research Excellence for Advanced Cooperative Systems285939 · FP7 · €3.4M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the ERC-AG funding scheme.
- What is the EU contribution?
- The European Commission contributes €1.8M toward a total project budget of €1.8M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by SVEUCILISTE U RIJECI, MEDICINSKI FAKULTET (HR).
- What is the project timeline?
- The project runs from 2013-05-01 to 2018-04-30 — approximately 5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 322693.